(0.70%) 5 163.76 points
(0.27%) 38 779 points
(0.79%) 16 283 points
(0.44%) $78.45
(4.67%) $2.24
(1.01%) $2 332.00
(3.57%) $27.64
(-0.08%) $964.50
(-0.08%) $0.928
(-0.45%) $10.83
(-0.16%) $0.796
(-0.13%) $91.33
0.00% $ 16.12
Live Chart Being Loaded With Signals
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics...
Stats | |
---|---|
Tagesvolumen | 36.00 |
Durchschnittsvolumen | 196.00 |
Marktkapitalisierung | 4.45B |
EPS | $0.190 ( 2023-06-30 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-05-14 |
Last Dividend | $0.0450 ( 2021-12-15 ) |
Next Dividend | $0 ( N/A ) |
P/E | 124.00 |
ATR14 | $0 (0.00%) |
Ambu A/S Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Ambu A/S Finanzdaten
Annual | 2023 |
Umsatz: | $4.78B |
Bruttogewinn: | $2.71B (56.82 %) |
EPS: | $0.650 |
FY | 2023 |
Umsatz: | $4.78B |
Bruttogewinn: | $2.71B (56.82 %) |
EPS: | $0.650 |
FY | 2022 |
Umsatz: | $4.44B |
Bruttogewinn: | $2.55B (57.47 %) |
EPS: | $0.370 |
FY | 2021 |
Umsatz: | $4.01B |
Bruttogewinn: | $2.50B (62.37 %) |
EPS: | $0.980 |
Financial Reports:
No articles found.
Ambu A/S Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0450 | 2021-12-15 |
Last Dividend | $0.0450 | 2021-12-15 |
Next Dividend | $0 | N/A |
Payout Date | 2021-12-31 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.0450 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.88 | -- |
Div. Sustainability Score | 9.76 | |
Div.Growth Potential Score | 2.74 | |
Div. Directional Score | 6.25 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OPHLF | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
CTUY | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
TYFG | Ex Dividend Junior | 2023-09-28 | Quarterly | 0 | 0.00% | |
ISMAY | Ex Dividend Knight | 2023-07-10 | Sporadic | 0 | 0.00% | |
BBBK | Ex Dividend Knight | 2023-09-18 | Quarterly | 0 | 0.00% | |
RBGLY | Ex Dividend Knight | 2023-08-04 | Semi-Annually | 0 | 0.00% | |
EJPRF | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
WEGRY | Ex Dividend Knight | 2023-10-05 | Annually | 0 | 0.00% | |
KRNTY | Ex Dividend Junior | 2023-05-25 | Annually | 0 | 0.00% | |
BXBLY | Ex Dividend Knight | 2023-09-13 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0486 | 1.500 | 9.03 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0348 | 1.200 | 8.84 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0448 | 1.500 | -0.614 | -0.921 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.37 | 0.800 | 3.17 | 2.54 | [1 - 3] |
quickRatioTTM | 1.191 | 0.800 | 7.70 | 6.16 | [0.8 - 2.5] |
cashRatioTTM | 0.327 | 1.500 | 9.29 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0918 | -1.500 | 8.47 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 12.00 | 1.000 | 6.67 | 6.67 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.02 | 2.00 | 8.99 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.881 | 2.00 | 9.06 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.116 | -1.500 | 9.54 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.570 | 1.000 | 3.84 | 3.84 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0735 | 1.000 | -0.530 | -0.530 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.282 | 1.000 | 3.99 | 3.99 | [0.2 - 2] |
assetTurnoverTTM | 0.716 | 0.800 | 8.56 | 6.85 | [0.5 - 2] |
Total Score | 9.76 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 130.52 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0448 | 2.50 | -0.395 | -0.921 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.881 | 2.00 | 9.37 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.02 | 2.00 | 8.99 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -9.14 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.164 | 1.000 | 8.39 | 0 | [0.1 - 0.5] |
Total Score | 2.74 |
Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, head immobilizers, CPR breathing barriers, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.